Stocks
Nektar Therapeutics (NKTR) EV/EBITDA US GAAP (year values) |
|||||||||
| FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | LTM ? | CAGR 5 years ? | |||
| EV/EBITDA | ? | -4.08 | 1.15 | 0.76 | -0.45 | -4.50 | -9.02 | ||
| Changes by years, y/y, % | -24% | -128% | -34% | -158% | +911% | -3.5% | |||
Nektar Therapeutics. EV/EBITDA
Nektar Therapeutics. EV/EBITDA, changes, %
Nektar Therapeutics (NKTR) EV/EBITDA US GAAP (quarter values) |
||||||||
| FY2025Q3 | FY2025Q4 | FY2026Q1 | FY2026Q2 | FY2026Q2 | LTM ? | |||
| EV/EBITDA | ? | -7.20 | -5.85 | -10.8 | -9.06 | -13.1 | -9.02 | |
| Changes by years, y/y, % | +630% | +1 096% | +4 093% | +178% | +302% | |||
| Changes by quarters, q/q, % | +121% | -19% | +84% | -16% | +45% | |||
